APO Research
Talk to an analyst

APO RESEARCH · REPORT

DTaP Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global DTaP Vaccine Industry Growth and Trends Forecast to 2032

19 December 202572 pages

Choose your research edition.

Industry ResearchDTaP Vaccine Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal DTaP Vaccine Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal DTaP Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DTaP Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal DTaP Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global DTaP Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for DTaP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for DTaP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DTaP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DTaP Vaccine include Merck, GlaxoSmithKline and Sanofi Pasteur, Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global DTaP Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The DTaP Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DTaP Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DTaP Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global DTaP Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

DTaP Vaccine Market by Company

Merck

GlaxoSmithKline

Sanofi Pasteur, Ltd.

DTaP Vaccine Segment by Type

Immune DTaP Vaccine

Therapy DTaP Vaccine

DTaP Vaccine Segment by Application

Adult

Pediatric

DTaP Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DTaP Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DTaP Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DTaP Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DTaP Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of DTaP Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immune DTaP Vaccine Table 2. Major Company of Therapy DTaP Vaccine Table 3. Global DTaP Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global DTaP Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global DTaP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global DTaP Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global DTaP Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global DTaP Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global DTaP Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global DTaP Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global DTaP Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global DTaP Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America DTaP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe DTaP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific DTaP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America DTaP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa DTaP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. DTaP Vaccine Industry Trends Table 25. DTaP Vaccine Industry Drivers Table 26. DTaP Vaccine Industry Opportunities and Challenges Table 27. DTaP Vaccine Industry Restraints Table 28. Global DTaP Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global DTaP Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global DTaP Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global DTaP Vaccine Sales Share by Company (2021-2026) Table 32. Global DTaP Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global DTaP Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global DTaP Vaccine Major Company Production Sites and Headquarters Table 35. Global DTaP Vaccine Company, Product Type & Application Table 36. Global DTaP Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global DTaP Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global DTaP Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global DTaP Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global DTaP Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global DTaP Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global DTaP Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global DTaP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global DTaP Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global DTaP Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global DTaP Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global DTaP Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global DTaP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global DTaP Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global DTaP Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global DTaP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global DTaP Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global DTaP Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global DTaP Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global DTaP Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global DTaP Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global DTaP Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global DTaP Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America DTaP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe DTaP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific DTaP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America DTaP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa DTaP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck DTaP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck DTaP Vaccine Product Portfolio Table 75. Merck Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline DTaP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GlaxoSmithKline DTaP Vaccine Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. Sanofi Pasteur, Ltd. Company Information Table 82. Sanofi Pasteur, Ltd. Business Overview Table 83. Sanofi Pasteur, Ltd. DTaP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolio Table 85. Sanofi Pasteur, Ltd. Recent Development Table 86. North America DTaP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 88. North America DTaP Vaccine Sales Market Share by Country (2021-2026) Table 89. North America DTaP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America DTaP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 91. North America DTaP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America DTaP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 93. North America DTaP Vaccine Market Share by Country (2021-2026) Table 94. North America DTaP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America DTaP Vaccine Market Share Forecast by Country (2027-2032) Table 96. Europe DTaP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 98. Europe DTaP Vaccine Sales Market Share by Country (2021-2026) Table 99. Europe DTaP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe DTaP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. Europe DTaP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe DTaP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe DTaP Vaccine Market Share by Country (2021-2026) Table 104. Europe DTaP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe DTaP Vaccine Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific DTaP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific DTaP Vaccine Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific DTaP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific DTaP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific DTaP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific DTaP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific DTaP Vaccine Market Share by Country (2021-2026) Table 114. Asia-Pacific DTaP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific DTaP Vaccine Market Share Forecast by Country (2027-2032) Table 116. Latin America DTaP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 118. Latin America DTaP Vaccine Sales Market Share by Country (2021-2026) Table 119. Latin America DTaP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America DTaP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America DTaP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America DTaP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America DTaP Vaccine Market Share by Country (2021-2026) Table 124. Latin America DTaP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America DTaP Vaccine Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa DTaP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa DTaP Vaccine Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa DTaP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa DTaP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa DTaP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa DTaP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa DTaP Vaccine Market Share by Country (2021-2026) Table 134. Middle East and Africa DTaP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa DTaP Vaccine Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. DTaP Vaccine Distributors List Table 139. DTaP Vaccine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. DTaP Vaccine Image Figure 2. Global DTaP Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DTaP Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global DTaP Vaccine Sales (2021-2032) & (K Units) Figure 5. Immune DTaP Vaccine Image Figure 6. Global Immune DTaP Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Therapy DTaP Vaccine Image Figure 8. Global Therapy DTaP Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global DTaP Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global DTaP Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America DTaP Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America DTaP Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe DTaP Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe DTaP Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific DTaP Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific DTaP Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America DTaP Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America DTaP Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa DTaP Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa DTaP Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 DTaP Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adult Image Figure 24. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pediatric Image Figure 26. Global Pediatric Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global DTaP Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global DTaP Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America DTaP Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America DTaP Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe DTaP Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe DTaP Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific DTaP Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific DTaP Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America DTaP Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America DTaP Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa DTaP Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa DTaP Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America DTaP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America DTaP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America DTaP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America DTaP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe DTaP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe DTaP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe DTaP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe DTaP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific DTaP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific DTaP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific DTaP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific DTaP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America DTaP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America DTaP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America DTaP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America DTaP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa DTaP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa DTaP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa DTaP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa DTaP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. DTaP Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. DTaP Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Immune DTaP Vaccine
  • Therapy DTaP Vaccine
Applications
  • Adult
  • Pediatric
Companies covered
  • Merck
  • GlaxoSmithKline
  • Sanofi Pasteur, Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DTaP Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global DTaP Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 DTaP Vaccine Market by Type
  6. 1.3.1 Immune DTaP Vaccine
  7. 1.3.2 Therapy DTaP Vaccine
  8. 1.4 Global DTaP Vaccine Market Size by Type
  9. 1.4.1 Global DTaP Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global DTaP Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global DTaP Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America DTaP Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe DTaP Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific DTaP Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America DTaP Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa DTaP Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 DTaP Vaccine Industry Trends
  2. 2.2 DTaP Vaccine Industry Drivers
  3. 2.3 DTaP Vaccine Industry Opportunities and Challenges
  4. 2.4 DTaP Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by DTaP Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by DTaP Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by DTaP Vaccine Price (2021-2026)
  4. 3.4 Global DTaP Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DTaP Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global DTaP Vaccine Company, Product Type & Application
  7. 3.7 Global DTaP Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DTaP Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DTaP Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DTaP Vaccine Tier 1, Tier 2, and Tier 3
4 DTaP Vaccine Regional Status and Outlook
  1. 4.1 Global DTaP Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global DTaP Vaccine Historic Market Size by Region
  3. 4.2.1 Global DTaP Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global DTaP Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global DTaP Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global DTaP Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global DTaP Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global DTaP Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global DTaP Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 DTaP Vaccine by Application
  1. 5.1 DTaP Vaccine Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Pediatric
  4. 5.2 Global DTaP Vaccine Market Size by Application
  5. 5.2.1 Global DTaP Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global DTaP Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global DTaP Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America DTaP Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe DTaP Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific DTaP Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America DTaP Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa DTaP Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck DTaP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck DTaP Vaccine Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline DTaP Vaccine Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Sanofi Pasteur, Ltd.
  14. 6.3.1 Sanofi Pasteur, Ltd. Company Information
  15. 6.3.2 Sanofi Pasteur, Ltd. Business Overview
  16. 6.3.3 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolio
  18. 6.3.5 Sanofi Pasteur, Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America DTaP Vaccine Sales by Country
  2. 7.1.1 North America DTaP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America DTaP Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America DTaP Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America DTaP Vaccine Market Size by Country
  6. 7.2.1 North America DTaP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America DTaP Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America DTaP Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe DTaP Vaccine Sales by Country
  2. 8.1.1 Europe DTaP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe DTaP Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe DTaP Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe DTaP Vaccine Market Size by Country
  6. 8.2.1 Europe DTaP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe DTaP Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe DTaP Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific DTaP Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific DTaP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific DTaP Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific DTaP Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific DTaP Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific DTaP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific DTaP Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific DTaP Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America DTaP Vaccine Sales by Country
  2. 10.1.1 South America DTaP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America DTaP Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America DTaP Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America DTaP Vaccine Market Size by Country
  6. 10.2.1 South America DTaP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America DTaP Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America DTaP Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa DTaP Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa DTaP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa DTaP Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa DTaP Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa DTaP Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa DTaP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa DTaP Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa DTaP Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 DTaP Vaccine Value Chain Analysis
  2. 12.1.1 DTaP Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 DTaP Vaccine Production Mode & Process
  7. 12.2 DTaP Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 DTaP Vaccine Distributors
  10. 12.2.3 DTaP Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst